| DG01641 | |
| DG number | DG01641 |
| Classification | DGroup |
| Name | CYP2C8 inhibitor |
| Stem | - |
| Structural formula | - |
| Member | DG00595 Trimethoprim D00145 Trimethoprim (JAN/USP/INN) D06236 Trimethoprim sulfate (USP) D08644 Trimethoprim lactate DG00946 Fluvoxamine D07984 Fluvoxamine (INN) D00824 Fluvoxamine maleate (JP17/USAN) DG01066 Montelukast D08229 Montelukast (INN) D00529 Montelukast sodium (JP17/USAN) D00334 Gemfibrozil (JAN/USP/INN) D00351 Ketoconazole (JP17/USP) D03669 Deferasirox (JAN/USAN/INN) |
| Upper group | Cyp inhibitor |
| Remark | - |
| Comment | - |
| Target | - |
| Metabolism | - |
| Interaction | CYP inhibition: CYP2C8 [HSA:1558] |